References
- Kishnani PS, Austin SL, Abdenur JE, Arn P, Bali DS, Boney A, et al. Diagnosis and management of glycogen storage disease type I: A practice guideline of the American College of Medical Genetics and Genomics. Genet Med. 2014; 16(11): e1.
- Dambska M, Labrador EB, Kuo CL, Weinstein DA. Prevention of complications in glycogen storage disease type Ia with optimization of metabolic control. Pediatr Diabetes. 2017; 18(5): 327-331.
- Sun A. Glucose-6-phosphatase deficiency (glycogen storage disease I, von Gierke disease). Hahn S, Editor. Waltham, MA, USA: UpToDate Inc. (https://www.upto date.com accessed February 16, 2018.
- Aydemir Y, Gurakan F, Saltik Temizel IN, Demir H, Karli Oguz K, et al. Evaluation of central nervous system in patients with glycogen storage disease type 1a. Turkish J Pediatr. 2016; 58(1): 12-18.
- Hufton BR, Wharton BA. Glycogen storage disease (type 1) presenting in the neonatal period. Arch Dis Child. 1982; 57(4): 309-319.
- Eminoğlu FT, Tümer L, Okur I, Ezgü FS, Hasanoğlu A. Clinical course and outcome of glycogen-storage disease type 1a and type 1b. Turk Arch Ped. 2013; 48(2): 117-122.
- Rake JP, Visser G, Labrune P, Leonard JV, Ullrich K, Smit GPK. Guidelines for management of glycogen storage disease type I – European Study on Glycogen Storage Disease Type I (ESGSD I). Eur J Pediatr. 2002; 161(Suppl 1): 112-119.